Novo Nordisk launches campaign for injectable weight-loss drug Wegovy
Novo Nordisk, the pharmaceutical company behind Ozempic, has launched a national campaign promoting its injectable weight-loss medication Wegovy. The Power of Wegovy highlights the individual results of its users while educating consumers on clinical data.